INULIN AND SODIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Inulin And Sodium Chloride, and when can generic versions of Inulin And Sodium Chloride launch?
Inulin And Sodium Chloride is a drug marketed by Iso Tex and is included in one NDA.
The generic ingredient in INULIN AND SODIUM CHLORIDE is inulin. There is one drug master file entry for this compound. Additional details are available on the inulin profile page.
Summary for INULIN AND SODIUM CHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Clinical Trials: | 43 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INULIN AND SODIUM CHLORIDE at DailyMed |
Recent Clinical Trials for INULIN AND SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | Phase 2 |
Centre Hospitalier Universitaire de Saint Etienne | Phase 1 |
Yanqing Li | Early Phase 1 |
US Patents and Regulatory Information for INULIN AND SODIUM CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iso Tex | INULIN AND SODIUM CHLORIDE | inulin | INJECTABLE;INJECTION | 002282-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |